Front Street Capital Management’s Carisma Therapeutics CARM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-2,150	Closed	-$44K	–	62
2019 Q1	$44K	Buy	2,150 +550	+34%	+$11.3K	0.01%	65
2018 Q4	$45K	Buy	1,600 +250	+19%	+$7.03K	0.01%	62
2018 Q3	$58K	Buy	+1,350	New	+$58K	0.02%	60